TrialVaccine2022

Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China.

Wang Shenyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.